AMNEAL PHARMACEUTICALS, INC. Total Liabilities and Equity
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Total Liabilities and Equity of $3.78 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-06
- 2026-06-30: Liabilities and Equity $3.78B.
- 2026-03-31: Liabilities and Equity $3.54B.
- 2025-12-31: Liabilities and Equity $3.68B.
- 2025-09-30: Liabilities and Equity $3.60B.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $3.78B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $3.54B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $3.68B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $3.60B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $3.42B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.37B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $3.50B 10-K · filed 2026-02-27 | |
| 2024-09-30 | $3.46B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.51B 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $3.46B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $3.47B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $3.69B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.70B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $3.63B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $3.80B 10-K · filed 2024-03-14 | |
| 2022-09-30 | $3.87B 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $4.04B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $3.89B 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $3.94B 10-K · filed 2023-03-03 | |
| 2021-09-30 | $3.97B 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $4.02B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $3.96B 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $4.01B 10-K · filed 2022-03-01 | |
| 2020-09-30 | $4.04B 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $4.06B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.39B 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.67B 10-K · filed 2021-03-01 | |
| 2019-09-30 | $3.70B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.26B 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $4.38B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.35B 10-K · filed 2020-03-02 | |
| 2018-09-30 | $4.58B 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $4.54B 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.34B 10-K · filed 2019-03-01 | $0.00 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |